Research Paper Volume 16, Issue 10 pp 8998—9022
Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles
Figure 7. (A) The Kaplan-Meier analysis of high and low risk group in the entire cohort, training and testing sets, respectively. P-values calculated by log-rank test. (B) The ROC curves for the 1-, 3-, and 5-year AUC values in the entire cohort, training, and testing sets, respectively. (C) Nomogram based on risk score and clinical variables was reliable and sensitive for predicting survival in patients with BC.